New differentiation antigens associated with the growth and maturation of B lymphocytes.

Monoclonal antibodies (mAb) NDA3 and NDA4 were generated by hyperimmunizing mice with an alloreactive human T cell clone and fusing the splenocytes with the NS1 myeloma. Immunofluorescence studies indicated that these mAb react with activated, but not with resting T and B lymphocytes or with other types of cells. Immunoprecipitation studies with 125-I-labeled extracts from T and B cell lines demonstrated that the m.w. of the antigen recognized by mAb NDA3 is 36,000 and that of NDA4 is 46,000. Studies on the effect of mAb NDA3 and NDA4 on Epstein Barr Virus-transformed lymphoblastoid B cell lines (LBCL) demonstrated that these antibodies stimulate B cell proliferation and Ig synthesis. The level of expression of NDA3 and NDA4 on the membrane of LBCL is significantly augmented when cells are grown in the presence of recombinant human interferon-beta and gamma and is decreased in the presence of 12-O-tetradecanoyl-phorbol-13-acetate. These observations, in conjunction with the stimulatory effect of mAb NDA3 and NDA4 on the growth and differentiation of LBCL, suggest that these new differentiation antigens, NDA3 and NDA4, may serve as growth factor receptors.

• Publication year

  1988

• Venue

  Journal of Immunology

• Publication date

  1988-01-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.4049/jimmunol.140.2.395PMID 2447175
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Use of the monoclonal antibody 12F1 to characterize the differentiation antigen VLA-2.

  1987cited by this paper
• Activation of human B cell proliferation through surface Bp35 (CD20) polypeptides or immunoglobulin receptors.

  1987cited by this paper
• Autocrine growth function of human interleukin 1 molecules on ROHA-9, an EBV-transformed human B cell line.

  1987cited by this paper
• Augmentation of normal and malignant B cell proliferation by monoclonal antibody to the B cell-specific antigen BP50 (CDW40).

  1987cited by this paper
• Purification and biochemical characterization of a human autocrine growth factor produced by Epstein-Barr virus-transformed B cells.

  1987cited by this paper
• Transmembrane Signals and Intracellular “Second Messengers” in the Regulation of Quiescent B‐Lymphocyte Activation

  1987cited by this paper
• Amplification of human B cell activation by a monoclonal antibody to the B cell-specific antigen CD22, Bp 130/140.

  1987cited by this paper
• Interferon-beta 2 living up to its name.

  1987cited by this paper
• B cell receptors for interleukin 2: demonstration of IL 2 internalization and of complementary effects of lipopolysaccharide and phorbol diester on receptor expression

  1986cited by this paper
• Quantitative determination of platelet surface alloantigens using a monoclonal probe.

  1986cited by this paper
• Immunology: Unravelling the control of B cells

  1986cited by this paper
• A role for Lyb-2 in B cell activation mediated by a B cell stimulatory factor.

  1986cited by this paper
• Regulation of class II gene expression: analysis in B cell stimulatory factor 1-inducible murine pre-B cell lines.

  1986cited by this paper
• Functional modifications of alloreactive T cell clones infected with HTLV-I.

  1986cited by this paper
• Expression and function of an early activation marker restricted to human B cells.

  1986cited by this paper
• Seeing the way to B-cell growth.

  1986cited by this paper
• Cloning of complementary DNA encoding T-cell replacing factor and identity with B-cell growth factor II

  1986cited by this paper
• Cloning of cDNA encoding the murine IgG1 induction factor by a novel strategy using SP6 promoter

  1986cited by this paper
• A monoclonal anti-mouse LFA-1 alpha antibody mimics the biological effects of B cell stimulatory factor-1 (BSF-1).

  1986cited by this paper
• Complementary DNA for a novel human interleukin (BSF-2) that induces B lymphocytes to produce immunoglobulin

  1986cited by this paper
• Binding of monoclonal antibody to the Epstein Barr virus (EBV)/CR2 receptor induces activation and differentiation of human B lymphocytes.

  1985cited by this paper
• A late-differentiation antigen associated with the helper inducer function of human T cells

  1985cited by this paper
• Rearrangement and transcription of the β-chain genes of the T-cell antigen receptor in different types of murine lymphocytes

  1985cited by this paper
• Role of the Bp35 cell surface polypeptide in human B-cell activation.

  1985cited by this paper
• The B cell surface molecule B1 is functionally linked with B cell activation and differentiation.

  1985cited by this paper
• Molecular events in B cell activation. I. Signals required to stimulate G0 to G1 transition of resting B lymphocytes.

  1985cited by this paper
• The CD20 (Bp35) antigen is involved in activation of B cells from the G0 to the G1 phase of the cell cycle.

  1985cited by this paper
• Stimulation of immunoglobulin secretion in human B lymphocytes as a direct effect of high concentrations of IL 2.

  1984cited by this paper
• Soluble factor requirements for the autostimulatory growth of B lymphoblasts immortalized by Epstein-Barr virus

  1984cited by this paper
• Ta1, a novel 105 KD human T cell activation antigen defined by a monoclonal antibody.

  1984cited by this paper
• Presence of T-cell receptor mRNA in functionally distinct T cells and elevation during intrathymic differentiation

  1984cited by this paper
• Selective inhibition of growth factor-dependent human B cell proliferation by monoclonal antibody AB1 to an antigen expressed by activated B cells

  1984cited by this paper
• Self-stimulating growth factor production by B-cell lines derived from Burkitt's lymphomas and other lines transformed in vitro by Epstein-Barr virus.

  1983cited by this paper
• Clonal differences in response to T cell replacing factor (TRF) for IgM secretion and TRF receptors in a human B lymphoblast cell line

  1983cited by this paper
• Expression and dynamics of membrane immunoglobulins.

  1982cited by this paper
• Epstein-Barr virus superinduces a new human B cell differentiation antigen (B-LAST 1) expressed on transformed lymphoblasts.

  1982cited by this paper
• A phorbol ester tumor promoter induces changes in the expression of immunoglobulins and DR antigens in human lymphoblastoid cells.

  1982cited by this paper
• Induction of IgG production in a human monoclonal B lymphoblastoid cell line by a B cell-specific monoclonal antibody.

  1982cited by this paper
• Membrane antigen on Epstein--Barr virus-infected human B cells recognized by a monoclonal antibody.

  1982cited by this paper
• IgG induction in a human B cell line by red cell-mediated microinjection of the cytoplasm from T cell factor-stimulated B cells.

  1982cited by this paper
• Identification of antigenic determinants unique to the surfaces of cells transformed by Epstein–Barr virus

  1981cited by this paper
• T cell-replacing factor- (TRF) induced IgG secretion in a human B blastoid cell line and demonstration of acceptors for TRF.

  1981cited by this paper
• Human antibody reacts with a B-cell subset in man to induce B-cell differentiation

  1980cited by this paper
• Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease.

  1979cited by this paper
• Conjugation of antibodies with fluorochromes: modifications to the standard methods.

  1976cited by this paper

• found predominantly on malignant B lymphocytes Identification and characterization of a new surface membrane antigen

  2011cites this paper
• Differentiation-stage specific self-peptides bound by major histocompatibility complex class I molecules

  1993cites this paper
• MHC class II binding of peptides derived from HLA-DR 1.

  1992cites this paper
• Biosynthesis and partial amino acid sequence of the human NDA4 antigen. An activation antigen common to B and T cell lineages.

  1991cites this paper
• In vitro effects of an immunotoxin reactive with a shared B and T cell activation antigen.

  1991cites this paper
• In vitro studies of the effect of MAb NDA 4 linked to toxin on the proliferation of a human EBV-transformed lymphoblastoid B cell line and of gibbon MLA leukemia cell line.

  1991cites this paper
• Identification and characterization of a new surface membrane antigen found predominantly on malignant B lymphocytes

  1990cites this paper
• Amplification of T cell blastogenic responses in healthy individuals and patients with acquired immunodeficiency syndrome.

  1990cites this paper
• Involvement of the multilineage CD38 molecule in a unique pathway of cell activation and proliferation.

  1990cites this paper
• Identification and characterization of a new surface membrane antigen found predominantly on malignant B lymphocytes.

  1990cites this paper
• Stimulation of Growth and Differentiation of EBV Transformed Cell Lines by Use of Monoclonal Antibodies to New Differentiation Antigens

  1989cites this paper
• Autostimulatory growth factors produced by Sjögren's syndrome B cell lines.

  1989cites this paper
• Anti-idiotypic antibodies regulate the immune response to HLA in heart allograft recipients.

  1989cites this paper
• Characterization of a Human B-Lymphocyte Antigen Associated with the Receptor for BCGF-12 kD

  1989cites this paper